ClinicalTrials.gov
public full text
Public Domain
Buprenorphine Dosing Interval - 5
The purpose of this study is to explore the feasibility of extending the dosing interval of well maintained buprenorphine patients to 48 and 72 hours, leading to eventual 3 times/week dosing.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Buprenorphine Maintenance for Opiate Dependence - 6#1282134
- Alternate-Day Buprenorphine Administration. Phase II - 4#839120
- Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder#879870
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1#874018
- Frontline Perspectives on Buprenorphine for the Management of Chronic Pain#683975
Record · ID 1320982
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive